메뉴 건너뛰기




Volumn 17, Issue 4, 2010, Pages 204-210

Disease-specific mortality may underestimate the total effect of prostate cancer screening

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 79251523513     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2010.010074     Document Type: Article
Times cited : (17)

References (26)
  • 1
    • 63249118690 scopus 로고    scopus 로고
    • Screening and prostate-cancer mortality in a randomized European study
    • Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8.
    • (2009) N Engl J Med , vol.360 , pp. 1320-1328
    • Schroder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 2
    • 0025179690 scopus 로고
    • The excess mortality rate. A useful concept in cancer epidemiology
    • Lenner P. The excess mortality rate. A useful concept in cancer epidemiology. Acta Oncol 1990;29:573-6.
    • (1990) Acta Oncol , vol.29 , pp. 573-576
    • Lenner, P.1
  • 3
    • 18844473657 scopus 로고    scopus 로고
    • The story of the European Randomized Study of Screening for Prostate Cancer
    • Schroder FH, Denis LJ, Roobol M, et al. The story of the European randomized study of screening for prostate cancer. BJU Int 2003;92(Suppl 2):1-13. (Pubitemid 38091131)
    • (2003) BJU International, Supplement , vol.92 , Issue.2 , pp. 1-13
    • Schroder, F.H.1    Denis, L.J.2    Roobol, M.3
  • 4
    • 0347756693 scopus 로고    scopus 로고
    • European randomized study of screening for prostate cancer: Achievements and presentation
    • Roobol MJ, Schroder FH. European randomized study of screening for prostate cancer: achievements and presentation. BJU Int 2003;92(Suppl 2):117-22.
    • (2003) BJU Int , vol.92 , Issue.SUPPL. 2 , pp. 117-122
    • Roobol, M.J.1    Schroder, F.H.2
  • 6
    • 0028832340 scopus 로고
    • Cancer incidence in the Netherlands in 1989 and 1990: First results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries
    • van der Sanden GA, Coebergh JW, Schouten LJ, Visser O, van Leeuwen FE. Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer 1995;31A:1822-9.
    • (1995) Eur J Cancer , vol.31 A , pp. 1822-1829
    • Van Der Sanden, G.A.1    Coebergh, J.W.2    Schouten, L.J.3    Visser, O.4    Van Leeuwen, F.E.5
  • 7
    • 79251520975 scopus 로고    scopus 로고
    • CBS. CBS. 2009;1. See http://statline.cbs.nl/StatWeb/publication.
    • (2009) CBS , vol.1
  • 8
    • 9144236203 scopus 로고    scopus 로고
    • Determining the cause of death in randomized screening trial(s) for prostate cancer
    • De Koning HJ, Blom J, Merkelbach JW, et al. Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int 2003;92(Suppl 2):71-8.
    • (2003) BJU Int , vol.92 , Issue.SUPPL. 2 , pp. 71-78
    • De Koning, H.J.1    Blom, J.2    Merkelbach, J.W.3
  • 11
    • 0037051107 scopus 로고    scopus 로고
    • Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial
    • de Koning HJ, Liem MK, Baan CA, Boer R, Schroder FH, Alexander FE. Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial. Int J Cancer 2002;98: 268-73.
    • (2002) Int J Cancer , vol.98 , pp. 268-273
    • De Koning, H.J.1    Liem, M.K.2    Baan, C.A.3    Boer, R.4    Schroder, F.H.5    Alexander, F.E.6
  • 12
    • 0021645157 scopus 로고
    • Additive and multiplicative models for relative survival rates
    • Buckley JD. Additive and multiplicative models for relative survival rates. Biometrics 1984;40:51-62.
    • (1984) Biometrics , vol.40 , pp. 51-62
    • Buckley, J.D.1
  • 14
    • 0031395394 scopus 로고    scopus 로고
    • Randomised trial of prostate cancer screening in the Netherlands: Assessment of acceptance and motives for attendance
    • Nijs HG, Tordoir DM, Schuurman JH, Kirkels WJ, Schroder FH. Randomised trial of prostate cancer screening in The Netherlands: assessment of acceptance and motives for attendance. J Med Screen 1997;4:102-6.
    • (1997) J Med Screen , vol.4 , pp. 102-106
    • Nijs, H.G.1    Tordoir, D.M.2    Schuurman, J.H.3    Kirkels, W.J.4    Schroder, F.H.5
  • 15
    • 3042604543 scopus 로고    scopus 로고
    • Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: Self-selection bias?
    • Otto SJ, Schroder FH, de Koning HJ. Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias? J Med Screen 2004;11:89-92.
    • (2004) J Med Screen , vol.11 , pp. 89-92
    • Otto, S.J.1    Schroder, F.H.2    De Koning, H.J.3
  • 16
  • 17
    • 84952496879 scopus 로고
    • A note on the delta method
    • Oehlert GW. A note on the delta method. Am Stat 1992;46:27-9.
    • (1992) Am Stat , vol.46 , pp. 27-29
    • Oehlert, G.W.1
  • 19
    • 0028968104 scopus 로고
    • Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee
    • Nystrom L, Larsson LG, Rutqvist LE, et al. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncol 1995; 34:145-52.
    • (1995) Acta Oncol , vol.34 , pp. 145-152
    • Nystrom, L.1    Larsson, L.G.2    Rutqvist, L.E.3
  • 21
    • 0033958329 scopus 로고    scopus 로고
    • A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995
    • Albertsen PC, Walters S, Hanley JA. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol 2000;163: 519-23.
    • (2000) J Urol , vol.163 , pp. 519-523
    • Albertsen, P.C.1    Walters, S.2    Hanley, J.A.3
  • 24
    • 0030340771 scopus 로고    scopus 로고
    • The Swedish randomised mammography screening trials: Analysis of their effect on the breast cancer related excess mortality
    • Larsson LG, Nystrom L, Wall S, et al. The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality. J Med Screen 1996;3:129-32.
    • (1996) J Med Screen , vol.3 , pp. 129-132
    • Larsson, L.G.1    Nystrom, L.2    Wall, S.3
  • 25
    • 0242592073 scopus 로고    scopus 로고
    • Service screening with mammography of women aged 70-74 years in Sweden: Effects on breast cancer mortality
    • DOI 10.1016/S0361-090X(03)00131-4
    • Jonsson H, Tornberg S, Nystrom L, Lenner P. Service screening with mammography of women aged 70-74 years in Sweden. Effects on breast cancer mortality. Cancer Detect Prev 2003;27:360-9. (Pubitemid 37374932)
    • (2003) Cancer Detection and Prevention , vol.27 , Issue.5 , pp. 360-369
    • Jonsson, H.1    Tornberg, S.2    Nystrom, L.3    Lenner, P.4
  • 26
    • 62849118351 scopus 로고    scopus 로고
    • Trials of prostate-cancer screening are not worthwhile
    • Dubben HH. Trials of prostate-cancer screening are not worthwhile. Lancet Oncol 2009;10:294-8.
    • (2009) Lancet Oncol , vol.10 , pp. 294-298
    • Dubben, H.H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.